STOCK TITAN

Cocrystal Pharma to Present at the Dawson James Securities 2022 Small Cap Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Cocrystal Pharma, Inc. (Nasdaq: COCP) has announced that James Martin, CFO and interim co-CEO, will present a company overview at the Dawson James Securities 2022 Small Cap Growth Conference on October 12, 2022, at 1:00 p.m. Eastern time. The event is scheduled at the Wyndham Grand Hotel in Jupiter, Florida. Mr. Martin will also be available for one-on-one meetings throughout the conference. The presentation will be accessible on the company's website starting October 12.

Positive
  • None.
Negative
  • None.

BOTHELL, Wash., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that James Martin, CFO and interim co-CEO, will present a company overview at the Dawson James Securities 2022 Small Cap Growth Conference on Wednesday, October 12, 2022 at 1:00 p.m. Eastern time (10:00 a.m. Pacific time). The conference is being held at the Wyndham Grand Hotel in Jupiter, Fla.

Mr. Martin is available throughout the conference for one-on-one meetings. The Cocrystal presentation will be posted to the IR Calendar of the Company’s website beginning October 12.

About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), hepatitis C viruses and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.

Investor Contact:
LHA Investor Relations
Jody Cain
310-691-7100
jcain@lhai.com

Media Contact:
JQA Partners
Jules Abraham
917-885-7378
Jabraham@jqapartners.com

# # #


FAQ

When will Cocrystal Pharma present at the Dawson James Securities Conference?

Cocrystal Pharma will present on October 12, 2022, at 1:00 p.m. Eastern time.

Who is presenting for Cocrystal Pharma at the conference?

James Martin, CFO and interim co-CEO, will present at the conference.

Where is the Dawson James Securities Conference being held?

The conference is being held at the Wyndham Grand Hotel in Jupiter, Florida.

Will the presentation be available online?

Yes, the presentation will be posted on Cocrystal Pharma's website starting October 12, 2022.

What does Cocrystal Pharma focus on?

Cocrystal Pharma focuses on developing antiviral therapeutics targeting influenza, coronaviruses, hepatitis C, and noroviruses.

Cocrystal Pharma, Inc.

NASDAQ:COCP

COCP Rankings

COCP Latest News

COCP Stock Data

21.47M
6.93M
31.85%
6.94%
0.02%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BOTHELL